Jasper Therapeutics, Inc. - Class A Common Stock
Jasper Therapeutics, Inc. - Class A Common Stock
Share · US4718712023 · JSPR (XNAS)
Overview Financial Indicators
5,85 USD
0,86 % 0,05 USD
NASDAQ (XNAS) · Current prices and charts at MoneyPeak
09.06.2025 21:51

Current Prices from Jasper Therapeutics, Inc. - Class A Common Stock

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
JSPR
USD
09.06.2025 21:51
5,85 USD
5,99 USD
-2,34 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % -0,85 % 30,00 % 8,94 % -73,88 % -76,14 % -93,99 %

Company Profile for Jasper Therapeutics, Inc. - Class A Common Stock Share

Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is also developing engineered hematopoietic stem cells product candidates to overcome key limitations of allogeneic and autologous gene-edited stem cell grafts. The company is based in Redwood City, California.

Company Data

Name Jasper Therapeutics, Inc. - Class A Common Stock
Company Jasper Therapeutics, Inc.
Symbol JSPR
Website https://jaspertherapeutics.com
Primary Exchange XNAS NASDAQ
ISIN US4718712023
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. Ronald A. Martell
Market Capitalization 60 Mio
Country United States of America
Currency USD
Employees 0,1 T
Address 2200 Bridge Pkwy, 94065 Redwood City
IPO Date 2020-01-10

ID Changes

Date From To
27.09.2021 AMHC JSPR

Ticker Symbols

Name Symbol
NASDAQ JSPR

More Shares

Investors who Jasper Therapeutics, Inc. - Class A Common Stock hold also have the following shares in their portfolio:
HITACHI CAPITAL (UK) PLC FLTNG RTE NTS DUE 01/09/2022
HITACHI CAPITAL (UK) PLC FLTNG RTE NTS DUE 01/09/2022 Bond
Telephone and Data Systems, Inc.
Telephone and Data Systems, Inc. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025